Attached files
| file | filename |
|---|---|
| EX-10.28 - EXHIBIT 10.28 - Aevi Genomic Medicine, Inc. | v398803_ex10-28.htm |
| EX-10.29 - EXHIBIT 10.29 - Aevi Genomic Medicine, Inc. | v398803_ex10-29.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Aevi Genomic Medicine, Inc. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - Aevi Genomic Medicine, Inc. | v398803_ex32-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Aevi Genomic Medicine, Inc. | v398803_ex21-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Aevi Genomic Medicine, Inc. | v398803_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Aevi Genomic Medicine, Inc. | v398803_ex31-1.htm |
| 10-K - FORM 10-K - Aevi Genomic Medicine, Inc. | v398803_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-170425, 333-182740 and 333-184431) and in the Registration Statements on Form S-8 (File Nos. 333-182992, 333-188709, 333-191733 and 333-195165) of Medgenics, Inc. of our reports dated February 13, 2015, with respect to the consolidated financial statements of Medgenics, Inc., and the effectiveness of internal control over financial reporting of Medgenics, Inc., included in this Annual Report of Medgenics, Inc. (Form 10-K) for the year ended December 31, 2014.
| /s/ KOST FORER GABBAY & KASIERER | |
| A member of EY Global |
Tel Aviv, Israel
February 13, 2015